• Did Neurocrine’s (NBIX) CRENESSITY Push Into Infants Just Recast Its Rare-Disease Strategy? simplywall.st Fri, 10 Jul 2026 02:27:41 GMT
• Form 4 Neurocrine Biosciences Inc For: 9 July By Investing.com Investing.com Canada Thu, 09 Jul 2026 22:52:42 GMT
• Neurocrine Biosciences chief regulatory officer sells $2.6m stock By Investing.com Investing.com Canada Thu, 09 Jul 2026 22:47:42 GMT
• Neurocrine (NBIX) officer sells 14,571 shares under Rule 10b5-1 plan Stock Titan Thu, 09 Jul 2026 22:41:30 GMT
• Form 144 NEUROCRINE BIOSCIENCES For: 9 July By Investing.com Investing.com Canada Thu, 09 Jul 2026 21:12:53 GMT
• 10,000 NBIX shares listed for sale; recent Darin Lippoldt 10b5-1 trades (NBIX) Stock Titan Thu, 09 Jul 2026 20:27:46 GMT
• Neurocrine's July 30 earnings call is scheduled for 4:30 p.m. ET Stock Titan Thu, 09 Jul 2026 20:03:29 GMT
• Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2026 Financial Results Yahoo Finance Thu, 09 Jul 2026 20:01:00 GMT
• neurocrine biosciences stock stays supported by a growing movement disorder portfolio Ad-hoc-news.de Thu, 09 Jul 2026 15:34:47 GMT
• Neurocrine Biosciences (NBIX) Stock Looks Fair On Earnings But Pricey Versus Biotechs Yahoo Finance Thu, 09 Jul 2026 02:14:00 GMT
• Neurocrine Biosciences (NBIX) Stock Looks Reasonable After Its 90% Run simplywall.st Wed, 08 Jul 2026 22:51:05 GMT
• Neurocrine Biosciences (NBIX) Could Be 8% Undervalued Following New Phase 2 Study Yahoo Finance Wed, 08 Jul 2026 22:15:09 GMT
• Neurocrine Biosciences (NBIX) Starts Phase 2 CAH Study In Children Under 4 Yahoo Finance Wed, 08 Jul 2026 21:16:52 GMT
• reasons why investors should consider betting on neurocrine stock MSN Wed, 08 Jul 2026 21:05:11 GMT
• Neurocrine (NBIX) Upgraded to Strong Buy: What Does It Mean for the Stock? Yahoo Finance Wed, 08 Jul 2026 16:00:04 GMT
• tardive dyskinesia market to grow rapidly at a cagr of 8.1% during the forecast period (2026-2036) | delveinsight Yahoo Finance Wed, 08 Jul 2026 14:31:00 GMT
• Neurocrine Biosciences stock hits all-time high at 176.1 USD Investing.com Tue, 07 Jul 2026 14:21:18 GMT
• RBC Capital Adjusts Neurocrine Biosciences Price Target to $195 From $183, Maintains Outperform Rating Moomoo Tue, 07 Jul 2026 11:22:35 GMT
• reasons why investors should consider betting on neurocrine stock Zacks Investment Research Mon, 06 Jul 2026 15:10:04 GMT
• neurocrine biosciences, inc. (nbix): analyst consensus and growth potential with a 12% upside DirectorsTalk Interviews Mon, 06 Jul 2026 09:23:54 GMT
• Enterprise value to EBIT forward of Neurocrine Biosciences, Inc. – NASDAQ:NBIX TradingView Sat, 04 Jul 2026 14:02:04 GMT
• Neurocrine Biosciences Inc (NASDAQ:NBIX) Shines in the "Little Book That Makes You Rich" Screen ChartMill Sat, 04 Jul 2026 08:30:29 GMT
• what neurocrine biosciences (nbix)'s index removal and ingrezza momentum means for shareholders Sahm Fri, 03 Jul 2026 10:59:02 GMT
• neurocrine biosciences inc (nbix) stock up 3.9% and still underv GuruFocus Fri, 03 Jul 2026 00:22:29 GMT
• Neurocrine Biosciences posts 44% revenue growth in Q1 2026, driven by key drugs and new acquisition. Pluang Thu, 02 Jul 2026 19:28:32 GMT
• Neurocrine Biosciences: Why I Am Upholding A Buy Rating After M&A Deal For Soleno (NBIX) Seeking Alpha Thu, 02 Jul 2026 18:55:01 GMT
• Zacks.com featured highlights include Neurocrine Biosciences, MYR Group, Block, Delek US Holdings and Dycom Industries Yahoo Finance Thu, 02 Jul 2026 13:37:00 GMT
• What Neurocrine Biosciences (NBIX)'s Index Removal and INGREZZA Momentum Means For Shareholders simplywall.st Thu, 02 Jul 2026 01:53:32 GMT
• neurocrine starts phase 2 trial of crinecerfont in infants with cah Investing.com Wed, 01 Jul 2026 20:30:53 GMT
• neurocrine biosciences initiates phase 2 study of crinecerfont in pediatric patients under 4 years old with classic congenital adr... PR Newswire Wed, 01 Jul 2026 20:05:00 GMT
• Neurocrine Biosciences (NBIX) Is Up 6.46% in One Week: What You Should Know Yahoo Finance Wed, 01 Jul 2026 16:00:03 GMT
• Neurocrine Biosciences Inc (NASDAQ:NBIX) Shows Strong Growth and Technical Breakout Setup ChartMill Wed, 01 Jul 2026 11:00:37 GMT
• Neurocrine (NBIX) Reports Clinically Meaningful Benefits in 94% of Patients Treated for Tardive Dyskinesia Yahoo Finance Wed, 01 Jul 2026 07:00:00 GMT
• Price to book forward of Neurocrine Biosciences, Inc. – NASDAQ:NBIX TradingView Wed, 01 Jul 2026 01:53:28 GMT
• Neurocrine Biosciences' Ingrezza Momentum Seen Supporting 2026 Guidance Upgrade, UBS Says Moomoo Tue, 30 Jun 2026 19:18:41 GMT
• UBS Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Raises Target Price to $208 Moomoo Tue, 30 Jun 2026 10:31:00 GMT
• Neurocrine (NBIX) legal chief exercises options and sells 10,000 shares Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• Neurocrine Biosciences and Ryanair have been highlighted as Zacks Bull and Bear of the Day Yahoo Finance Mon, 29 Jun 2026 07:00:00 GMT
• Neurocrine Biosciences stock hits all-time high at 169.62 USD Investing.com Mon, 29 Jun 2026 07:00:00 GMT
• Neurocrine Biosciences, Inc.(NasdaqGS: NBIX) dropped from Russell 1000 Dynamic Index marketscreener.com Mon, 29 Jun 2026 00:46:19 GMT
• neurocrine biosciences (nbix) unveils new crenessity data for classic cah and rare subtype Yahoo Finance Sun, 28 Jun 2026 11:07:58 GMT
• Neurocrine Biosciences (NBIX): High Growth NASDAQ Stocks to Buy Now Yahoo Finance Sun, 28 Jun 2026 07:00:00 GMT
• Neurocrine Biosciences (NBIX) Is Up 6.5% After CRENESSITY Shows Broad CAH Benefits at ENDO 2026 – Has The Bull Case Changed? Yahoo Finance Sun, 28 Jun 2026 07:00:00 GMT
• Neurocrine Biosciences (NBIX) Showed New CRENESSITY Data, Is The Stock Still Cheap? simplywall.st Sun, 28 Jun 2026 07:00:00 GMT
• Neurocrine Biosciences (NBIX): High Growth Stocks to Buy Right Now Yahoo Finance Sat, 27 Jun 2026 07:00:00 GMT
• neurocrine biosciences (nbix): high growth nasdaq stocks to buy now Yahoo Finance Sat, 27 Jun 2026 07:00:00 GMT
• neurocrine biosciences, inc. actuals & estimates (nasdaq:nbix) TradingView Sat, 27 Jun 2026 02:54:18 GMT
• form 144 neurocrine biosciences inc for: 26 june by investing.com Investing.com Nigeria Sat, 27 Jun 2026 00:40:29 GMT
• form 144 neurocrine biosciences inc for: 26 june by investing.com Investing.com Canada Fri, 26 Jun 2026 22:06:30 GMT
• price to earnings forward of neurocrine biosciences, inc. – nasdaq:nbix TradingView Fri, 26 Jun 2026 18:05:28 GMT
• enterprise value to ebit forward of neurocrine biosciences, inc. – dus:nb3 TradingView Fri, 26 Jun 2026 11:22:53 GMT
• neurocrine biosciences, inc. shs unsponsored brazilian depositary receipt repr 0.05 sh TradingView Fri, 26 Jun 2026 07:52:30 GMT
• neurocrine biosciences inc (nbix) financial health: profitability & balance sheet analysis TradingKey Fri, 26 Jun 2026 07:51:20 GMT
• enterprise value to revenue forward of neurocrine biosciences, inc. – dus:nb3 TradingView Fri, 26 Jun 2026 05:51:35 GMT
• enterprise value to ebitda forward of neurocrine biosciences, inc. – dus:nb3 TradingView Fri, 26 Jun 2026 02:57:15 GMT
• price to sales forward of neurocrine biosciences, inc. – dus:nb3 TradingView Fri, 26 Jun 2026 00:32:47 GMT
• costco stock and 2 low risk picks built for volatile markets simplywall.st Fri, 26 Jun 2026 00:26:57 GMT
• neurocrine biosciences inc (nbix) valuation: pe, pb & fair value analysis TradingKey Thu, 25 Jun 2026 07:00:00 GMT
• neurocrine biosciences (nasdaq:nbix) fits the profile of a classic garp stock under the peter lynch framework ChartMill Wed, 24 Jun 2026 12:10:32 GMT
• neurocrine biosciences inc (nbix) institutional confidence TradingKey Wed, 24 Jun 2026 10:19:24 GMT
• neurocrine biosciences inc (nbix) valuation: pe, pb & fair value analysis TradingKey Wed, 24 Jun 2026 10:17:06 GMT
• neurocrine biosciences inc (nbix) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 24 Jun 2026 09:03:35 GMT
• Is Neurocrine (NBIX) a Solid Growth Stock? 3 Reasons to Think "Yes" Yahoo Finance Wed, 24 Jun 2026 07:00:00 GMT
• what neurocrine biosciences (nbix)'s new crenessity cah data means for shareholders Sahm Tue, 23 Jun 2026 08:01:15 GMT
• stifel reiterates neurocrine bio stock rating on vykat potential Investing.com Mon, 22 Jun 2026 14:27:41 GMT
• what neurocrine biosciences (nbix)'s new crenessity cah data means for shareholders simplywall.st Mon, 22 Jun 2026 13:42:10 GMT
• neurocrine biosciences, inc. (nbix) stock analysis: a 22.8% potential upside amid strong growth prospects DirectorsTalk Interviews Mon, 22 Jun 2026 09:17:59 GMT
• neurocrine biosciences inc (nbix) financial health: profitability & balance sheet analysis TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• neurocrine biosciences inc (nbix) earnings forecast: future eps & revenue growth estimates TradingKey Sun, 21 Jun 2026 07:00:00 GMT
• Neurocrine Biosciences Inc (NASDAQ:NBIX): A Decent Value Play with Strong Fundamentals ChartMill Sat, 20 Jun 2026 07:00:00 GMT
• neurocrine biosciences (nbix) stock could be 18% undervalued after endo 2026 crenessity data simplywall.st Fri, 19 Jun 2026 07:00:00 GMT
• neurocrine biosciences inc (nbix) valuation: pe, pb & fair value analysis TradingKey Fri, 19 Jun 2026 04:45:30 GMT
• neurocrine biosciences inc (nbix) institutional confidence TradingKey Fri, 19 Jun 2026 03:16:00 GMT
• neurocrine biosciences inc (nbix) financial health: profitability & balance sheet analysis TradingKey Fri, 19 Jun 2026 01:47:06 GMT
• neurocrine biosciences inc (nbix) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 19:31:30 GMT
• neurocrine biosciences inc (nbix) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 19:18:20 GMT
• neurocrine biosciences inc (nbix) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 18:52:40 GMT
• neurocrine biosciences inc (nbix) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• soleno therapeutics presents new vykat xr data at endo The Pharma Letter Tue, 16 Jun 2026 14:52:26 GMT
• neurocrine presents crenessity case series in rare cah subtype BioSpectrum Asia Tue, 16 Jun 2026 11:17:04 GMT
• neurocrine biosciences (nasdaq:nbix) screens as a high-growth momentum breakout candidate ChartMill Tue, 16 Jun 2026 10:40:33 GMT
• neurocrine presents case study on crenessity for rare cah subtype Investing.com UK Tue, 16 Jun 2026 10:39:34 GMT
• citi maintains neurocrine biosciences(nbix.us) with buy rating, maintains target price $246 Moomoo Tue, 16 Jun 2026 07:00:00 GMT
• neurocrine presents long-term data on prader-willi drug by investing.com Investing.com South Africa Tue, 16 Jun 2026 03:15:13 GMT
• neurocrine biosciences (nbix) presents new vykat xr (diazoxide choline) data StreetInsider Mon, 15 Jun 2026 23:06:31 GMT
• neurocrine presents long-term data on prader-willi drug Investing.com Mon, 15 Jun 2026 21:00:09 GMT
• neurocrine presents case study on crenessity for rare cah subtype Investing.com Mon, 15 Jun 2026 20:25:30 GMT
• soleno therapeutics presents new vykat® xr (diazoxide choline) data at endo 2026 demonstrating meaningful and durable improvements... PR Newswire Mon, 15 Jun 2026 20:10:00 GMT
• 3-year vykat xr trial eases hyperphagia, behaviors in pws Stock Titan Mon, 15 Jun 2026 20:10:00 GMT
• neurocrine biosciences (nbix) presents first retrospective case series of crenessity StreetInsider Mon, 15 Jun 2026 20:07:21 GMT
• two-year data show crenessity slows bone age pr... | pluang – crypto, stocks, gold & funds Pluang Mon, 15 Jun 2026 17:27:38 GMT
• neurocrine (nbix) reports positive phase 3 data on crenessity GuruFocus Mon, 15 Jun 2026 14:43:50 GMT
• two-year data bolster neurocrine’s crenessity case in pediatric cah The Pharma Letter Mon, 15 Jun 2026 14:36:00 GMT
• neurocrine presents 2-year crenessity data at endo 2026 Investing.com Mon, 15 Jun 2026 13:09:08 GMT
• neurocrine presents two-year pediatric data for crenessity Investing.com Mon, 15 Jun 2026 12:59:30 GMT
• neurocrine presents two-year crenessity data showing growth improvements StreetInsider Mon, 15 Jun 2026 12:37:18 GMT
• two-year trial drug tied to taller height in children with cah Stock Titan Mon, 15 Jun 2026 12:35:00 GMT
• neurocrine shows two-year crenessity data at endo 2026 medical meeting StreetInsider Mon, 15 Jun 2026 12:31:18 GMT
• neurocrine biosciences, inc. (nbix) stock analysis: investor outlook highlights 20.73% potential upside DirectorsTalk Interviews Mon, 15 Jun 2026 09:15:15 GMT
• Is Neurocrine Biosciences, Inc. (NBIX) A Good Stock To Buy Now? Yahoo Finance Mon, 15 Jun 2026 07:00:00 GMT
• Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Demonstrating Improvements in Cardiometabolic Outcome... PR Newswire Mon, 15 Jun 2026 07:00:00 GMT
• neurocrine biosciences presents first retrospective case series of crenessity® (crinecerfont) in patients with classic congenital ... The Grand Junction Daily Sentinel Mon, 15 Jun 2026 07:00:00 GMT
• how new ingrezza td data in underserved patients could shape neurocrine biosciences’ (nbix) investment story simplywall.st Sun, 14 Jun 2026 07:00:00 GMT
• marquis who's who honors noah post for expertise in pharmaceuticals 24-7 Press Release Newswire Fri, 12 Jun 2026 07:01:16 GMT
• assessing neurocrine biosciences (nbix) valuation after recent share price momentum Sahm Fri, 12 Jun 2026 07:00:00 GMT
• ingrezza data in complex patients adds support for neurocrine valuation story simplywall.st Wed, 10 Jun 2026 23:46:49 GMT
• neurocrine biosciences inc (nasdaq:nbix): a growth stock pick from the little book strategy ChartMill Wed, 10 Jun 2026 07:00:00 GMT
• neurocrine biosciences(nbix.us) director sells us$4.13 million in common stock Moomoo Wed, 10 Jun 2026 03:46:34 GMT
• neurocrine biosciences director stephen a. sherwin sells $4.13m stock Investing.com UK Wed, 10 Jun 2026 02:30:06 GMT
• transcript : neurocrine biosciences, inc. presents at goldman sachs 47th annual global healthcare conference 2026, jun-09-2026 09 marketscreener.com Tue, 09 Jun 2026 15:35:43 GMT
• neurocrine biosciences (nbix) goldman sachs 47th annual global healthcare conference 2026 summary Quartr Tue, 09 Jun 2026 14:22:38 GMT
• neurocrine biosciences(nbix.us) director sells us$4.13 million in common stock Moomoo Tue, 09 Jun 2026 07:00:00 GMT
• [form 4] neurocrine biosciences inc insider trading activity Stock Titan Tue, 09 Jun 2026 07:00:00 GMT
• neurocrine biosciences director stephen a. sherwin sells $4.13m stock Investing.com Tue, 09 Jun 2026 07:00:00 GMT
• neurocrine (nbix) director exercises 25k options and sells 25k shares under 10b5-1 plan Stock Titan Tue, 09 Jun 2026 07:00:00 GMT
• cerebral palsy market positioned for significant commercial growth by 2036 – delveinsight | neurocrine biosciences, teva pharma, b... Barchart.com Tue, 09 Jun 2026 00:22:09 GMT
• ingrezza shows rapid improvement in tardive dyskinesia and daily function in patients with intellectual disabilities Pluang Mon, 08 Jun 2026 16:55:57 GMT
• neurocrine reports positive ingrezza data for td in patients with idd grafa.com Mon, 08 Jun 2026 12:52:19 GMT
• neurocrine presents data on tardive dyskinesia treatment Investing.com Mon, 08 Jun 2026 12:46:31 GMT
• doctors report td reductions, better speech and socializing with ingrezza Stock Titan Mon, 08 Jun 2026 12:30:00 GMT
• Neurocrine Biosciences Presents New Data Highlighting Functional and Socio-emotional Improvements with INGREZZA® (valbenazine) Cap... PR Newswire Mon, 08 Jun 2026 07:00:00 GMT
• Neurocrine Biosciences Presents New Clinically Meaningful Response Data on Treatment of Tardive Dyskinesia, Reinforcing the Effica... PR Newswire Mon, 08 Jun 2026 07:00:00 GMT
• neurocrine biosciences director sells $210,071 in stock Investing.com Mon, 08 Jun 2026 07:00:00 GMT
• neurocrine biosciences inc (nasdaq:nbix) nears technical breakout with near-perfect score ChartMill Mon, 08 Jun 2026 07:00:00 GMT
• neurocrine (nbix) director sells 1,250 shares under rule 10b5-1 plan Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• drug for uncontrollable movements eased symptoms in 94% of patients over 48 weeks Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• neurocrine publishes dosing guidelines for cah treatment drug Investing.com Sat, 06 Jun 2026 09:36:31 GMT
• neurocrine biosciences inc. (nbix) stock price | live quotes & charts | nasdaq StocksToTrade Sat, 06 Jun 2026 00:36:00 GMT
• behavioral patterns of nbix and institutional flows Stock Traders Daily Fri, 05 Jun 2026 19:36:01 GMT
• oppenheimer raises neurocrine biosciences price target on acquisition Investing.com Fri, 05 Jun 2026 10:01:34 GMT
• neurocrine biosciences insider sold shares worth $5,770,235, according to a recent sec filing Moomoo Fri, 05 Jun 2026 07:00:00 GMT
• does neurocrine biosciences’ (nbix) rare disease push quietly rewire its endocrine risk-reward profile? simplywall.st Fri, 05 Jun 2026 07:00:00 GMT
• truist raises neurocrine bio stock price target on strong sales Investing.com Fri, 05 Jun 2026 07:00:00 GMT
• oppenheimer raises neurocrine bio stock price target on strong results Investing.com Fri, 05 Jun 2026 07:00:00 GMT
Neurocrine Biosciences, Inc(NASDAQ:NBIX) 
Neurocrine Biosciences, Inc., a biopharmaceutical company, discovers, develops, and markets pharmaceutical products for the treatment of neurological, endocrine, and psychiatric-based diseases and disorders in the United States. The company offers INGREZZA, a VMAT2 inhibitor for the treatment of tar...
Website: http://www.neurocrine.com
Founded: 1992
Full Time Employees: 825
Sector: Healthcare
Industry: Biotechnology